Skip to main content

Table 2 Perioperative outcomes of GC patients

From: Efficacy and safety of totally laparoscopic gastrectomy with uncut Roux-en-Y for gastric cancer: a dual-center retrospective study

Variables

URY

RY

P†

N

138

104

 

Operative time (min)

204.83 ± 49.85

229.08 ± 51.44

< 0.001

Intraoperative anastomosis time (min)

35.37 ± 9.38

45.63 ± 8.13

< 0.001

Intraoperative blood loss (ml)

95.07 ± 49.47

176.56 ± 165.24

< 0.001

LOS (days)

8.29 ± 2.55

10.33 ± 4.45

< 0.001

Intake time of liquid food (days)

2.63 ± 0.87

3.98 ± 1.97

< 0.001

Postoperative chemotherapy; N (%)

61 (44.20)

34 (32.69)

0.069

Postoperative mortality in 30 days; N (%)

0 (0.00)

2 (1.92)

0.358

Overall short-term postoperative complications; N (%)a

16 (11.59)

32 (30.77)

< 0.001

Pneumonia; N (%)

4 (2.90)

7 (6.73)

0.269

Fever; N (%)

2 (1.45)

6 (5.77)

0.134

Pleural effusion; N (%)

2 (1.45)

6 (5.77)

0.134

Gastric paralysis; N (%)

2 (1.45)

4 (3.85)

0.442

Other; N (%)

6 (4.35)

9 (8.65)

0.169

Serious complications (Clavien III-V); N (%)

5 (3.62)

10 (9.62)

0.056

  1. GC gastric cancer, LOS length of hospital stay
  2. †Continuity correction, Pearson’s x2 test, or Student’s t-test was used to analyze the basic characteristics
  3. aAccording to the Clavien–Dindo classification